Fsd Pharma Inc (HUGE)

$0.5969

-0.02

(-3.12%)

Market is closed - opens 7 PM, 15 Apr 2024

Insights on Fsd Pharma Inc

  • Vs NBIX

    In the last 1 year, Neurocrine Biosciences Inc. has given 31.0% return, outperforming this stock by 98.9%

  • Vs NBIX

    In the last 3 years, Neurocrine Biosciences Inc. has given 41.7% return, outperforming this stock by 108.0%

Performance

  • $0.60
    $0.62
    $0.60
    downward going graph

    0.83%

    Downside

    Day's Volatility :3.57%

    Upside

    2.76%

    downward going graph
  • $0.56
    $2.10
    $0.60
    downward going graph

    7.32%

    Downside

    52 Weeks Volatility :73.52%

    Upside

    71.43%

    downward going graph

Returns

PeriodFsd Pharma IncIndex (Russel 2000)
3 Months
-34.45%
0.0%
6 Months
-49.42%
0.0%
1 Year
-67.91%
-0.7%
3 Years
-66.28%
-21.3%

Highlights

Market Capitalization
24.3M
Book Value
$0.38
Earnings Per Share (EPS)
-0.58
PEG Ratio
0.0
Wall Street Target Price
6.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-48.64%
Return On Equity TTM
-89.32%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
-7.3999999999999995%
Gross Profit TTM
-3.3M
EBITDA
-20.9M
Diluted Eps TTM
-0.58
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Fsd Pharma Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 905.19%

Current $0.60
Target $6.00

Technicals Summary

Sell

Neutral

Buy

Fsd Pharma Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fsd Pharma Inc
Fsd Pharma Inc
-18.68%
-49.42%
-67.91%
-66.28%
-92.13%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
-3.23%
18.54%
31.02%
41.67%
58.78%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
-2.67%
-2.91%
-9.18%
8.1%
8.1%
Zoetis Inc.
Zoetis Inc.
-13.75%
-14.39%
-14.1%
-8.03%
48.11%
Viatris Inc.
Viatris Inc.
-4.15%
19.64%
14.79%
-14.23%
-30.66%
Catalent, Inc.
Catalent, Inc.
-0.71%
21.02%
21.55%
-48.78%
26.77%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fsd Pharma Inc
Fsd Pharma Inc
NA
NA
0.0
0.0
-0.89
-0.49
NA
0.38
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
55.91
55.91
0.45
4.77
0.13
0.09
NA
22.61
Haleon Plc Spon Ads
Haleon Plc Spon Ads
28.17
28.17
1.71
0.46
0.07
0.04
0.02
1.8
Zoetis Inc.
Zoetis Inc.
32.19
32.19
2.81
5.8
0.5
0.13
0.01
10.9
Viatris Inc.
Viatris Inc.
232.9
232.9
NA
2.78
0.0
0.03
0.04
17.05
Catalent, Inc.
Catalent, Inc.
211.02
NA
2.08
0.45
-0.3
-0.01
NA
20.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fsd Pharma Inc
Fsd Pharma Inc
Buy
$24.3M
-92.13%
NA
0.0%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$13.7B
58.78%
55.91
13.23%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$37.3B
8.1%
28.17
9.28%
Zoetis Inc.
Zoetis Inc.
Buy
$74.7B
48.11%
32.19
27.43%
Viatris Inc.
Viatris Inc.
Hold
$13.8B
-30.66%
232.9
0.35%
Catalent, Inc.
Catalent, Inc.
Hold
$10.3B
26.77%
211.02
-31.77%

Institutional Holdings

  • AdvisorShares Investments, LLC

    0.69%
  • Renaissance Technologies Corp

    0.18%
  • Scotia Capital Inc

    0.16%
  • UBS Group AG

    0.07%
  • Group One Trading, LP

    0.04%
  • TWO SIGMA SECURITIES, LLC

    0.03%

Company Information

fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.

Organization
Fsd Pharma Inc
Employees
17
CEO
Mr. Zeeshan Saeed
Industry
Process Industries

FAQs